Therapeutic Advances in Musculoskeletal Disease.
What has become equally clear however, is that autoimmune inflammation is only one part of the equation, with an underlying cytodegeneration beginning early and continuing relentlessly throughout the course of the disease
Heterologous expression, purification, and enzymatic activity of Mycobacterium [PMID: 12182838] Laboratory literature summary: Heterologous expression, purification, and enzymatic activity of Mycobacterium tuberculosis NAD(+) synthetase
BPC stands for Body Protection Compound
See the latest compounding review, FDA docket updates, and what researchers need to know
Its unique properties and broad spectrum of potential therapeutic applications have positioned it as a subject of intense investigation